International Flavors & Fragrances Health & Biosciences — Research and development expenses remained flat by 0.0% to $55.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $52.00M to $55.00M. Over 3 years (FY 2022 to FY 2025), Health & Biosciences — Research and development expenses shows an upward trend with a 9.7% CAGR.
Higher spending signals a commitment to long-term growth and product differentiation, though it impacts short-term margins.
Expenditures dedicated to the discovery, development, and improvement of proprietary formulations and specialty ingredie...
Standard R&D expense reported by technology and specialty chemical companies.
iff_segment_health_biosciences_research_and_development_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.50M | $41.50M | $41.50M | $41.50M | $43.00M | $43.00M | $43.00M | $43.00M | $46.00M | $50.00M | $44.00M | $50.00M | $52.00M | $55.00M | $57.00M | $55.00M | $55.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.6% | +0.0% | +0.0% | +0.0% | +7.0% | +8.7% | -12.0% | +13.6% | +4.0% | +5.8% | +3.6% | -3.5% | +0.0% |
| YoY Change | — | — | — | — | +3.6% | +3.6% | +3.6% | +3.6% | +7.0% | +16.3% | +2.3% | +16.3% | +13.0% | +10.0% | +29.5% | +10.0% | +5.8% |